| AGX |
| @Monksdream |
01/25/2025 7:56:32 PM |
| back in the day (2020) it was a |
| @Jester_vandalay |
05/27/2024 9:10:26 PM |
| 193.00 Game-Changer: The FDA Approved Eye Drops That |
| @Hamzaali |
12/14/2021 6:42:00 AM |
| Please dont invest your grandkids money here. |
| @Nachomonge |
06/02/2021 11:47:06 AM |
| It doesn't look to be trading? |
| @AJACKS |
04/06/2021 5:18:02 PM |
| What happened here rcookr1? |
| @nowmrida |
03/19/2021 12:59:37 AM |
| That's a wrap! |
| @CyberCall |
05/08/2020 8:58:23 PM |
| $ABBV completes $65B$ AGN acquisition: |
| @farml1234 |
05/08/2020 8:57:14 PM |
| 1Q20 worldwide Botox sales=$812.2M, -6% YoY, -20% QoQ*: |
| @mattmile92 |
05/08/2020 7:00:30 PM |
| $ABBV-AGN merger expected to close 5/8/20: |
| @marieburdon |
05/06/2020 4:48:14 PM |
| Following FTC agreement, $ABBV-AGN plan May 2020 |
| @singhvj2000 |
03/17/2020 9:31:19 PM |
| $ABBV-AGN receive EU approval for mergerUS FTC approval |
| @ejjoe001 |
03/03/2020 2:31:48 PM |
| 4Q19 worldwide Botox sales=$1.020B, +8% YoY, +10% QoQ*: |
| @ASMIntegrator |
02/10/2020 5:48:22 PM |
| FDA approves $AGNs Ubrelvy (ubrogepant) for acute migraine treatment: |
| @fishbonematt |
12/23/2019 8:23:55 PM |
| 3Q19 worldwide Botox sales=$928.7M, +6% YoY, -5% QoQ*: |
| @2416842176cd131303ac92591cecbf |
11/05/2019 3:11:51 PM |
| 2Q19 worldwide Botox sales=$974.0M, +4% YoY, +12% QoQ*: |
| @jal9t9 |
08/06/2019 11:58:18 AM |
| agn looking to buy $EYEN. still a |
| @BigBallz |
06/25/2019 3:28:58 PM |
| LOL. These lawsuit PRs are pre-written fill-in-the-blanks forms |
| @Dpdtrader78 |
06/25/2019 3:04:08 PM |
| News: $AGN Allergan Merger Investigation: Halper Sadeh LLP |
| @ |
06/25/2019 2:50:25 PM |
| $ABBV-AGN CC slides: |
| @urion80 |
06/25/2019 2:02:47 PM |
| News: $AGN AbbVie to Acquire Allergan in Transformative |
| @ |
06/25/2019 1:50:30 PM |
| RF-frequency devices for aesthetic applications go back at |
| @Edwardseg |
06/24/2019 6:41:34 PM |
| The Zeltiq device is cryogenic and seems to |
| @powell2954 |
06/24/2019 6:17:52 PM |
| ~ 60% more effective then laser removal. Shorter |
| @Jesseclark |
05/11/2019 9:06:21 PM |
| I would question the business plan of any |
| @Jalapenohiway |
05/11/2019 9:03:00 PM |
| In regards to $AGN.. Has anyone heard of |
| @Rumeshdias |
05/11/2019 3:21:25 PM |
| $AGN 1Q19 CC transcript: |
| @suzannedieze |
05/08/2019 3:13:34 PM |
| $AGN 1Q19 CC slides: |
| @bdgerard |
05/07/2019 2:49:01 PM |
| (From $AGNs PR)1Q19 worldwide Botox sales=$868.4M, +6% YoY |
| @Rolz225 |
05/07/2019 2:45:24 PM |
| $AGN 1Q19 results: |
| @Harper |
05/07/2019 2:45:06 PM |
| Abicipar pegol (a/k/a DARPin) shows 8.9% ocular inflammation |
| @Zachrady |
04/02/2019 1:42:23 PM |
| Three phase-3 Rapastinel trials stopped for futility: |
| @RichardPClemenceau |
03/06/2019 10:56:23 PM |
| $AGN 4Q18 CC transcript: |
| @Laolieu |
01/30/2019 2:08:49 PM |
| $AGN 4Q18 CC slides: |
| @f6f3e0c8165b5a77091df1ddd0bd18 |
01/29/2019 1:58:24 PM |
| $AGN 4Q18 results: |
| @dmc284 |
01/29/2019 1:23:17 PM |
| News: $AGN CoolSculpting® and Sonja Morgan Partner To |
| @ |
01/15/2019 5:16:24 PM |
| $AGN -7% on permanent recall of textured breast |
| @c1aca0638eca81d22de5846d54b17e |
12/19/2018 6:55:56 PM |
| $AGN 3Q18 CC transcript: |
| @Beavis20 |
10/30/2018 6:48:41 PM |
| Reason for todays selloff: #msg-144555471. |
| @ckrutulis1 |
10/30/2018 6:47:55 PM |
| $AGN 3Q18 results items |
| @sajjad1423 |
10/30/2018 12:20:08 PM |
| $AGN slides from AAO webcast: |
| @khan |
10/29/2018 9:27:45 PM |
| $AGN slides from Medical Aesthetics Day: |
| @LucasCTS |
09/14/2018 7:14:18 PM |
| Re: AGN's internal long-acting toxin |
| @POPAURMAA1 |
09/14/2018 3:20:39 PM |
| $AGN acquires (private) Bonti for $195M plus contingencies: |
| @wjack12412 |
09/14/2018 2:12:43 PM |
| $AGN receives CRL for Ulipristal treatment for uterine fibroids: |
| @Bigsurf |
08/21/2018 9:56:09 PM |
| $AGN,$ EDIT announce mutual opt-ins on$ EDIT-101: #msg-142720697. |
| @kunaladitya |
08/06/2018 8:19:22 PM |
| More granularity of 2Q18 Botox sales: #msg-142479825. |
| @frankyvee |
07/27/2018 12:34:42 PM |
| Transcript of $AGN 2Q18 CC: |
| @Bhushan |
07/27/2018 12:33:47 PM |
| $AGN 2Q18 items |
| @groovyweb |
07/26/2018 4:09:02 PM |
| $AGN/MOLN.SW report phase-3$ AMD data for Abicipar (a/k/a DARPin): |
| @01474471 |
07/19/2018 3:17:15 PM |